| Angela Pailthorpe, PA-C | |
|
4045 W Royal Dr, Traverse City, MI 49684-8965 | |
| (231) 929-5734 | |
| (231) 935-0312 |
| Full Name | Angela Pailthorpe |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 3 Years |
| Location | 4045 W Royal Dr, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083358436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 5601011101 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Skin Cancer And Dermatology Center Plc | 5597012096 | 4 |
News Archive
People at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have healthy patterns of glucose metabolism in their brain, according to a new UW-Madison study.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either because they relapsed, had a partial response or had a null response.
Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients - a phenomenon described as the "inverse benefit law" in a paper from the University of Texas Medical Branch at Galveston.
An analysis of the state marketplace by First Data released Thursday found serious problems with management and communications.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela Pailthorpe, PA-C 4045 W Royal Dr, Traverse City, MI 49684-8965 Ph: (231) 929-5734 | Angela Pailthorpe, PA-C 4045 W Royal Dr, Traverse City, MI 49684-8965 Ph: (231) 929-5734 |
News Archive
People at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have healthy patterns of glucose metabolism in their brain, according to a new UW-Madison study.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either because they relapsed, had a partial response or had a null response.
Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients - a phenomenon described as the "inverse benefit law" in a paper from the University of Texas Medical Branch at Galveston.
An analysis of the state marketplace by First Data released Thursday found serious problems with management and communications.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
› Verified 1 days ago
Jeffrey Arbour, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1105 Sixth St, Traverse City, MI 49684 Phone: 231-935-0497 | |
Ms. Stacy Zachman Dobreff, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3537 W Front St Ste E, Traverse City, MI 49684 Phone: 231-935-8930 | |
John Gabriel Tazzi, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3537 W Front St Ste E, Traverse City, MI 49684 Phone: 231-935-5880 Fax: 319-353-4642 | |
Mrs. Kolleen Bartosek, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1225 W Front St Ste C, Traverse City, MI 49684 Phone: 231-642-5031 Fax: 231-525-2306 | |
Derek Hendrickson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth St Ste 200, Traverse City, MI 49684 Phone: 231-935-5800 Fax: 231-935-5799 | |
Ronald L Sanders, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 550 Munson Ave, Traverse City, MI 49686 Phone: 231-935-8686 | |
Mr. Howard V. Tyree, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4075 Copper Ridge Dr, Traverse City, MI 49684 Phone: 231-946-8970 Fax: 231-932-4118 |